aluates Reports

$ 0.0

Automative

Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2024

Published Date: May 2024

Report Code: QYRE-Auto-16K13344

Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2023

BUY CHAPTERS

Global B Cell Maturation Antigen Targeted Therapy Market Research Report 2024

Code: QYRE-Auto-16K13344

Report

May 2024

Pages:91

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

GlaxoSmithKline PLC

Johnson & Johnson

Amgen Inc

Seagen

AbbVie

Novartis

BioTherapeutics

Celgene

Bluebird bio

Bristol Mayer Squibb

CARsgen Therapeutics

Juno Therapeutics

Cogent Bioscience

CRISPR Therapeutics

Allogene Therapeutics

Harpoon Therapeutics

Poseida Therapeutics

B Cell Maturation Antigen Targeted Therapy Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

B Cell Maturation Antigen Targeted Therapy Market

The global B Cell Maturation Antigen Targeted Therapy market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for B Cell Maturation Antigen Targeted Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding B Cell Maturation Antigen Targeted Therapy.

Report Scope

The B Cell Maturation Antigen Targeted Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global B Cell Maturation Antigen Targeted Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the B Cell Maturation Antigen Targeted Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of B Cell Maturation Antigen Targeted Therapy Market Report

Report Metric	Details
Report Name	B Cell Maturation Antigen Targeted Therapy Market
CAGR	5%
Segment by Type	Antibody-Drug Conjugates CAR-T Cells and Bispecific T Cell Engagers
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GlaxoSmithKline, Johnson & Johnson, Amgen, Seagen, AbbVie, Novartis, BioTherapeutics, Celgene, Bluebird Bio, Bristol Mayer Squibb, Carsgen Therapeutics, Juno Therapeutics, Cogent Bioscience, CRISPR Therapeutics, Allogene Therapeutics, Harpoon Therapeutics, Poseida Therapeutics
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of B Cell Maturation Antigen Targeted Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the B Cell Maturation Antigen Targeted Therapy Market report?

Ans: The main players in the B Cell Maturation Antigen Targeted Therapy Market are GlaxoSmithKline, Johnson & Johnson, Amgen, Seagen, AbbVie, Novartis, BioTherapeutics, Celgene, Bluebird Bio, Bristol Mayer Squibb, Carsgen Therapeutics, Juno Therapeutics, Cogent Bioscience, CRISPR Therapeutics, Allogene Therapeutics, Harpoon Therapeutics, Poseida Therapeutics

What are the Application segmentation covered in the B Cell Maturation Antigen Targeted Therapy Market report?

Ans: The Applications covered in the B Cell Maturation Antigen Targeted Therapy Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the B Cell Maturation Antigen Targeted Therapy Market report?

Ans: The Types covered in the B Cell Maturation Antigen Targeted Therapy Market report are Antibody-Drug Conjugates, CAR-T Cells and Bispecific T Cell Engagers

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antibody-Drug Conjugates

1.2.3 CAR-T Cells and Bispecific T Cell Engagers

1.3 Market by Application

1.3.1 Global B Cell Maturation Antigen Targeted Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global B Cell Maturation Antigen Targeted Therapy Market Perspective (2019-2030)

2.2 B Cell Maturation Antigen Targeted Therapy Growth Trends by Region

2.2.1 Global B Cell Maturation Antigen Targeted Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 B Cell Maturation Antigen Targeted Therapy Historic Market Size by Region (2019-2024)

2.2.3 B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Region (2025-2030)

2.3 B Cell Maturation Antigen Targeted Therapy Market Dynamics

2.3.1 B Cell Maturation Antigen Targeted Therapy Industry Trends

2.3.2 B Cell Maturation Antigen Targeted Therapy Market Drivers

2.3.3 B Cell Maturation Antigen Targeted Therapy Market Challenges

2.3.4 B Cell Maturation Antigen Targeted Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top B Cell Maturation Antigen Targeted Therapy Players by Revenue

3.1.1 Global Top B Cell Maturation Antigen Targeted Therapy Players by Revenue (2019-2024)

3.1.2 Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Players (2019-2024)

3.2 Global B Cell Maturation Antigen Targeted Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by B Cell Maturation Antigen Targeted Therapy Revenue

3.4 Global B Cell Maturation Antigen Targeted Therapy Market Concentration Ratio

3.4.1 Global B Cell Maturation Antigen Targeted Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by B Cell Maturation Antigen Targeted Therapy Revenue in 2023

3.5 B Cell Maturation Antigen Targeted Therapy Key Players Head office and Area Served

3.6 Key Players B Cell Maturation Antigen Targeted Therapy Product Solution and Service

3.7 Date of Enter into B Cell Maturation Antigen Targeted Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 B Cell Maturation Antigen Targeted Therapy Breakdown Data by Type

4.1 Global B Cell Maturation Antigen Targeted Therapy Historic Market Size by Type (2019-2024)

4.2 Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Type (2025-2030)

5 B Cell Maturation Antigen Targeted Therapy Breakdown Data by Application

5.1 Global B Cell Maturation Antigen Targeted Therapy Historic Market Size by Application (2019-2024)

5.2 Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)

6.2 North America B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)

6.4 North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)

7.2 Europe B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)

7.4 Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)

8.2 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)

9.2 Latin America B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)

9.4 Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size (2019-2030)

10.2 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GlaxoSmithKline

11.1.1 GlaxoSmithKline Company Detail

11.1.2 GlaxoSmithKline Business Overview

11.1.3 GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Introduction

11.1.4 GlaxoSmithKline Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.1.5 GlaxoSmithKline Recent Development

11.2 Johnson & Johnson

11.2.1 Johnson & Johnson Company Detail

11.2.2 Johnson & Johnson Business Overview

11.2.3 Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Introduction

11.2.4 Johnson & Johnson Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.2.5 Johnson & Johnson Recent Development

11.3 Amgen

11.3.1 Amgen Company Detail

11.3.2 Amgen Business Overview

11.3.3 Amgen B Cell Maturation Antigen Targeted Therapy Introduction

11.3.4 Amgen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.3.5 Amgen Recent Development

11.4 Seagen

11.4.1 Seagen Company Detail

11.4.2 Seagen Business Overview

11.4.3 Seagen B Cell Maturation Antigen Targeted Therapy Introduction

11.4.4 Seagen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.4.5 Seagen Recent Development

11.5 AbbVie

11.5.1 AbbVie Company Detail

11.5.2 AbbVie Business Overview

11.5.3 AbbVie B Cell Maturation Antigen Targeted Therapy Introduction

11.5.4 AbbVie Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.5.5 AbbVie Recent Development

11.6 Novartis

11.6.1 Novartis Company Detail

11.6.2 Novartis Business Overview

11.6.3 Novartis B Cell Maturation Antigen Targeted Therapy Introduction

11.6.4 Novartis Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.6.5 Novartis Recent Development

11.7 BioTherapeutics

11.7.1 BioTherapeutics Company Detail

11.7.2 BioTherapeutics Business Overview

11.7.3 BioTherapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.7.4 BioTherapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.7.5 BioTherapeutics Recent Development

11.8 Celgene

11.8.1 Celgene Company Detail

11.8.2 Celgene Business Overview

11.8.3 Celgene B Cell Maturation Antigen Targeted Therapy Introduction

11.8.4 Celgene Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.8.5 Celgene Recent Development

11.9 Bluebird Bio

11.9.1 Bluebird Bio Company Detail

11.9.2 Bluebird Bio Business Overview

11.9.3 Bluebird Bio B Cell Maturation Antigen Targeted Therapy Introduction

11.9.4 Bluebird Bio Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.9.5 Bluebird Bio Recent Development

11.10 Bristol Mayer Squibb

11.10.1 Bristol Mayer Squibb Company Detail

11.10.2 Bristol Mayer Squibb Business Overview

11.10.3 Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Introduction

11.10.4 Bristol Mayer Squibb Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.10.5 Bristol Mayer Squibb Recent Development

11.11 Carsgen Therapeutics

11.11.1 Carsgen Therapeutics Company Detail

11.11.2 Carsgen Therapeutics Business Overview

11.11.3 Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.11.4 Carsgen Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.11.5 Carsgen Therapeutics Recent Development

11.12 Juno Therapeutics

11.12.1 Juno Therapeutics Company Detail

11.12.2 Juno Therapeutics Business Overview

11.12.3 Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.12.4 Juno Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.12.5 Juno Therapeutics Recent Development

11.13 Cogent Bioscience

11.13.1 Cogent Bioscience Company Detail

11.13.2 Cogent Bioscience Business Overview

11.13.3 Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Introduction

11.13.4 Cogent Bioscience Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.13.5 Cogent Bioscience Recent Development

11.14 CRISPR Therapeutics

11.14.1 CRISPR Therapeutics Company Detail

11.14.2 CRISPR Therapeutics Business Overview

11.14.3 CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.14.4 CRISPR Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.14.5 CRISPR Therapeutics Recent Development

11.15 Allogene Therapeutics

11.15.1 Allogene Therapeutics Company Detail

11.15.2 Allogene Therapeutics Business Overview

11.15.3 Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.15.4 Allogene Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.15.5 Allogene Therapeutics Recent Development

11.16 Harpoon Therapeutics

11.16.1 Harpoon Therapeutics Company Detail

11.16.2 Harpoon Therapeutics Business Overview

11.16.3 Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.16.4 Harpoon Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.16.5 Harpoon Therapeutics Recent Development

11.17 Poseida Therapeutics

11.17.1 Poseida Therapeutics Company Detail

11.17.2 Poseida Therapeutics Business Overview

11.17.3 Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Introduction

11.17.4 Poseida Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

11.17.5 Poseida Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

GlaxoSmithKline PLC

Johnson & Johnson

Amgen Inc

Seagen

AbbVie

Novartis

BioTherapeutics

Celgene

Bluebird bio

Bristol Mayer Squibb

CARsgen Therapeutics

Juno Therapeutics

Cogent Bioscience

CRISPR Therapeutics

Allogene Therapeutics

Harpoon Therapeutics

Poseida Therapeutics

List of Tables

Table 1. Global B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antibody-Drug Conjugates

Table 3. Key Players of CAR-T Cells and Bispecific T Cell Engagers

Table 4. Global B Cell Maturation Antigen Targeted Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 5. Global B Cell Maturation Antigen Targeted Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 7. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region (2019-2024)

Table 8. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 9. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region (2025-2030)

Table 10. B Cell Maturation Antigen Targeted Therapy Market Trends

Table 11. B Cell Maturation Antigen Targeted Therapy Market Drivers

Table 12. B Cell Maturation Antigen Targeted Therapy Market Challenges

Table 13. B Cell Maturation Antigen Targeted Therapy Market Restraints

Table 14. Global B Cell Maturation Antigen Targeted Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 15. Global B Cell Maturation Antigen Targeted Therapy Market Share by Players (2019-2024)

Table 16. Global Top B Cell Maturation Antigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Cell Maturation Antigen Targeted Therapy as of 2023)

Table 17. Ranking of Global Top B Cell Maturation Antigen Targeted Therapy Companies by Revenue (US$ Million) in 2023

Table 18. Global 5 Largest Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 19. Key Players Headquarters and Area Served

Table 20. Key Players B Cell Maturation Antigen Targeted Therapy Product Solution and Service

Table 21. Date of Enter into B Cell Maturation Antigen Targeted Therapy Market

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global B Cell Maturation Antigen Targeted Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 24. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Type (2019-2024)

Table 25. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 26. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Type (2025-2030)

Table 27. Global B Cell Maturation Antigen Targeted Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 28. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Application (2019-2024)

Table 29. Global B Cell Maturation Antigen Targeted Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 30. Global B Cell Maturation Antigen Targeted Therapy Revenue Market Share by Application (2025-2030)

Table 31. North America B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 32. North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 33. North America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 34. Europe B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 35. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 36. Europe B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 37. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 38. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 39. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 40. Latin America B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 41. Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 42. Latin America B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 43. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 44. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 45. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 46. GlaxoSmithKline Company Detail

Table 47. GlaxoSmithKline Business Overview

Table 48. GlaxoSmithKline B Cell Maturation Antigen Targeted Therapy Product

Table 49. GlaxoSmithKline Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 50. GlaxoSmithKline Recent Development

Table 51. Johnson & Johnson Company Detail

Table 52. Johnson & Johnson Business Overview

Table 53. Johnson & Johnson B Cell Maturation Antigen Targeted Therapy Product

Table 54. Johnson & Johnson Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 55. Johnson & Johnson Recent Development

Table 56. Amgen Company Detail

Table 57. Amgen Business Overview

Table 58. Amgen B Cell Maturation Antigen Targeted Therapy Product

Table 59. Amgen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 60. Amgen Recent Development

Table 61. Seagen Company Detail

Table 62. Seagen Business Overview

Table 63. Seagen B Cell Maturation Antigen Targeted Therapy Product

Table 64. Seagen Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 65. Seagen Recent Development

Table 66. AbbVie Company Detail

Table 67. AbbVie Business Overview

Table 68. AbbVie B Cell Maturation Antigen Targeted Therapy Product

Table 69. AbbVie Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 70. AbbVie Recent Development

Table 71. Novartis Company Detail

Table 72. Novartis Business Overview

Table 73. Novartis B Cell Maturation Antigen Targeted Therapy Product

Table 74. Novartis Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 75. Novartis Recent Development

Table 76. BioTherapeutics Company Detail

Table 77. BioTherapeutics Business Overview

Table 78. BioTherapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 79. BioTherapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 80. BioTherapeutics Recent Development

Table 81. Celgene Company Detail

Table 82. Celgene Business Overview

Table 83. Celgene B Cell Maturation Antigen Targeted Therapy Product

Table 84. Celgene Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 85. Celgene Recent Development

Table 86. Bluebird Bio Company Detail

Table 87. Bluebird Bio Business Overview

Table 88. Bluebird Bio B Cell Maturation Antigen Targeted Therapy Product

Table 89. Bluebird Bio Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 90. Bluebird Bio Recent Development

Table 91. Bristol Mayer Squibb Company Detail

Table 92. Bristol Mayer Squibb Business Overview

Table 93. Bristol Mayer Squibb B Cell Maturation Antigen Targeted Therapy Product

Table 94. Bristol Mayer Squibb Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 95. Bristol Mayer Squibb Recent Development

Table 96. Carsgen Therapeutics Company Detail

Table 97. Carsgen Therapeutics Business Overview

Table 98. Carsgen Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 99. Carsgen Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 100. Carsgen Therapeutics Recent Development

Table 101. Juno Therapeutics Company Detail

Table 102. Juno Therapeutics Business Overview

Table 103. Juno Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 104. Juno Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 105. Juno Therapeutics Recent Development

Table 106. Cogent Bioscience Company Detail

Table 107. Cogent Bioscience Business Overview

Table 108. Cogent Bioscience B Cell Maturation Antigen Targeted Therapy Product

Table 109. Cogent Bioscience Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 110. Cogent Bioscience Recent Development

Table 111. CRISPR Therapeutics Company Detail

Table 112. CRISPR Therapeutics Business Overview

Table 113. CRISPR Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 114. CRISPR Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 115. CRISPR Therapeutics Recent Development

Table 116. Allogene Therapeutics Company Detail

Table 117. Allogene Therapeutics Business Overview

Table 118. Allogene Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 119. Allogene Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 120. Allogene Therapeutics Recent Development

Table 121. Harpoon Therapeutics Company Detail

Table 122. Harpoon Therapeutics Business Overview

Table 123. Harpoon Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 124. Harpoon Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 125. Harpoon Therapeutics Recent Development

Table 126. Poseida Therapeutics Company Detail

Table 127. Poseida Therapeutics Business Overview

Table 128. Poseida Therapeutics B Cell Maturation Antigen Targeted Therapy Product

Table 129. Poseida Therapeutics Revenue in B Cell Maturation Antigen Targeted Therapy Business (2019-2024) & (US$ Million)

Table 130. Poseida Therapeutics Recent Development

Table 131. Research Programs/Design for This Report

Table 132. Key Data Information from Secondary Sources

Table 133. Key Data Information from Primary Sources

List of Figures

Figure 1. Global B Cell Maturation Antigen Targeted Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global B Cell Maturation Antigen Targeted Therapy Market Share by Type: 2023 VS 2030

Figure 3. Antibody-Drug Conjugates Features

Figure 4. CAR-T Cells and Bispecific T Cell Engagers Features

Figure 5. Global B Cell Maturation Antigen Targeted Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 6. Global B Cell Maturation Antigen Targeted Therapy Market Share by Application: 2023 VS 2030

Figure 7. Hospitals Case Studies

Figure 8. Clinics Case Studies

Figure 9. Others Case Studies

Figure 10. B Cell Maturation Antigen Targeted Therapy Report Years Considered

Figure 11. Global B Cell Maturation Antigen Targeted Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 12. Global B Cell Maturation Antigen Targeted Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 13. Global B Cell Maturation Antigen Targeted Therapy Market Share by Region: 2023 VS 2030

Figure 14. Global B Cell Maturation Antigen Targeted Therapy Market Share by Players in 2023

Figure 15. Global Top B Cell Maturation Antigen Targeted Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in B Cell Maturation Antigen Targeted Therapy as of 2023)

Figure 16. The Top 10 and 5 Players Market Share by B Cell Maturation Antigen Targeted Therapy Revenue in 2023

Figure 17. North America B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 18. North America B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)

Figure 19. United States B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. Canada B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 21. Europe B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Europe B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)

Figure 23. Germany B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. France B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. U.K. B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Italy B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. Russia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Nordic Countries B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Asia-Pacific B Cell Maturation Antigen Targeted Therapy Market Share by Region (2019-2030)

Figure 31. China B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Japan B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. South Korea B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Southeast Asia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. India B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Australia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. Latin America B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Latin America B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)

Figure 39. Mexico B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Brazil B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Middle East & Africa B Cell Maturation Antigen Targeted Therapy Market Share by Country (2019-2030)

Figure 43. Turkey B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Saudi Arabia B Cell Maturation Antigen Targeted Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. GlaxoSmithKline Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 46. Johnson & Johnson Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 47. Amgen Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 48. Seagen Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 49. AbbVie Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 50. Novartis Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 51. BioTherapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 52. Celgene Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 53. Bluebird Bio Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 54. Bristol Mayer Squibb Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 55. Carsgen Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 56. Juno Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 57. Cogent Bioscience Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 58. CRISPR Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 59. Allogene Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 60. Harpoon Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 61. Poseida Therapeutics Revenue Growth Rate in B Cell Maturation Antigen Targeted Therapy Business (2019-2024)

Figure 62. Bottom-up and Top-down Approaches for This Report

Figure 63. Data Triangulation

Figure 64. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Next Generation Antibody Drug Market Research Report 2024

Global Immune Drugs Market Insights Forecast to 2030

Global Targeted Drugs for Multiple Myeloma Market Research Report 2024

Global Clinical Grade Antibody Portfolio Market Research Report 2025

Global Chimeric Antigen Receptor Cell Therapy Market Research Report 2024

Global Therapeutic BCG Vaccines Market Insights Forecast to 2030

Tumor Immunotherapy Market

Antibody Drug Conjugate Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Next Generation Immunology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Monoclonal Antibody Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Myeloid Cells Targeting Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Cancers Immunotherapy Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024

Global Targeted Drugs for Breast Cancer Market Research Report 2024

Global Antigen Home Diagnostic Testing Market Research Report 2025

Cell Therapy Technologies Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global B Cell Chronic Lymphocytic Leukemia Treatment Market Research Report 2024

Image Guided Therapy Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global CAR T Cellular Immunotherapy Drug Market Research Report 2024

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions